BIOL - バイオレ―ズ （Biolase Inc.） バイオレ―ズBIOLのチャート
BIOLの企業情報
| symbol | BIOL |
|---|---|
| 会社名 | Biolase Inc （バイオレ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 バイオレーサー・テクノロジー(BIOLASE Technology Inc)は歯科用レーザー会社。同社は医療技術会社であり、歯科用レーザーの開発・製造・販売、及び技術中心型の歯科用イメージング機器と製品の流通・販売に従事する。同社のレーザー製品は疼痛の減少、回復時間の加速を実現できる技術を採用した。同社の製品は美容および外科アプリケーションを含む一連の歯科治療を行う歯科用レーザーシステム、及び一連の歯科用イメージング機器を含む。他の開発中の製品は眼科や他の医療およびコンシューマ市場を目当てにする。 バイオレ―ズは米国の歯科・医療機器メ―カ―。主要製品はレ―ザ―エネルギ―と水を組み合わせたレ―ザ―システムWaterLase(ウォ―タ―レ―ズ)。患者にとってより安全で痛みを軽減した治療法を提供。またレ―ザ―ホワイトニングと治療の為のEpicｈやワイヤレス歯科レ―ザ―iLase、動物用レ―ザ―Epic Vシリ―ズなども展開。 |
| 本社所在地 | 4 Cromwell Irvine CA 92618 USA |
| 代表者氏名 | Jonathan T. Lord ジョナサン・T・ロード |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 949-361-1200 |
| 設立年月日 | 31809 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 195人 |
| url | www.biolase.com |
| nasdaq_url | https://www.nasdaq.com/symbol/biol |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -17.70500 |
| 終値（lastsale） | 1.53 |
| 時価総額（marketcap） | 31513258.53 |
| 時価総額 | 時価総額（百万ドル） 32.13117 |
| 売上高 | 売上高（百万ドル） 45.61400 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 29.31617 |
| 当期純利益 | 当期純利益（百万ドル） 2.71400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 BIOLASE Inc revenues decreased 6% to $22.2M. Net loss applicable to common stockholders decreased 20% to $9.9M. Revenues reflect United States segment decrease of 14% to $12.9M. Lower net loss reflects others decrease of 20% to $2.5M (expense) Sales and Marketing - Balancing value decrease of 3% to $8.3M (expense). |
BIOLのテクニカル分析
BIOLのニュース
Dental Lasers Market 2021-2027 Top Key Players | AMD LASERS, Biolase, Inc, FOTONA D.D, Convergent Dental 2021/02/19 11:08:14 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Dental Lasers Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Dental Lasers Market is expected to witness growth in upcoming years due to factors such as increase in target patient
BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering 2021/02/10 21:05:00 PR Newswire
FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less…
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering 2021/02/06 02:42:00 PR Newswire
IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis,…
Dental Lasers Market 2021 - 2027 Global Opportunity Analysis, Industry Size, Share, Growth, Future Market Trends, Top Key Players: AMD LASERS, Biolase, Inc, FOTONA D.D, Convergent Dental, Ivoclar Vivadent AG 2021/01/28 07:39:17 OpenPR
Allied Market Research published a new report, titled, "Dental Lasers Market Global Opportunity Analysis and Industry Forecast, 2021-2027". The report has offered an all-inclusive analysis of the global Dental Lasers Market taking into consideration all the crucial aspects like growth factors,
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement 2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering 2021/02/06 02:42:00 PR Newswire
IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis,…
Dental Lasers Market 2021 - 2027 Global Opportunity Analysis, Industry Size, Share, Growth, Future Market Trends, Top Key Players: AMD LASERS, Biolase, Inc, FOTONA D.D, Convergent Dental, Ivoclar Vivadent AG 2021/01/28 07:39:17 OpenPR
Allied Market Research published a new report, titled, "Dental Lasers Market Global Opportunity Analysis and Industry Forecast, 2021-2027". The report has offered an all-inclusive analysis of the global Dental Lasers Market taking into consideration all the crucial aspects like growth factors,
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement 2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
BIOLASE Announces Preliminary Fourth Quarter Revenue Results And Current Cash Position 2021/01/26 13:30:00 PR Newswire
FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth quarter ended December 31, 2020. The Company also announced its current cash position of…
BIOLASE, INC : Submission of Matters to a Vote of Security Holders (form 8-K) | MarketScreener 2021/01/22 21:25:07 MarketScreener
Item 5.07. Submission of Matters to a Vote of Security Holders. On January 22, 2021, BIOLASE, Inc., a Delaware corporation , held a special meeting of stockholders . At the meeting, the Company's… | January 22, 2021
BIOLASE Announces Launch On M-Vest 2020/10/27 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Oct. 27, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has made available an updated corporate presentation and business summary overview on M-Vest.com. The Company plans to provide regular updates…
Laser Therapy Market Is Expected To Reach US$ 3,514.02 Million By 2027 With Alma Lasers ,Coherent, Inc. ,biolitec Group ,BIOLASE, Inc. ,IPG Photonics Corporation ,Boston Scientific Corporation ,BTL 2020/10/23 10:09:06 OpenPR
Laser Therapy Market Is Expected To Reach US$ 3,514.02 Million By 2027 From US$ 1,665.65 Million In 2019; It Is Estimated To Grow At A CAGR Of 9.9% From 2020 To 2027. The key players profiled in the Laser Therapy Market
Contrasting Envista (NYSE:NVST) and BIOLASE (NYSE:BIOL) 2020/10/20 09:30:50 Dakota Financial News
Envista (NYSE:NVST) and BIOLASE (NASDAQ:BIOL) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Profitability This table compares Envista and BIOLASE’s net margins, return on equity and return on assets. Net Margins […]
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth 2020/10/14 11:30:00 PR Newswire
FOOTHILL RANCH, Calif., Oct. 14, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quarter ended September 30, 2020. The Company expects to report third quarter revenue in the range of…
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis 2020/09/15 12:30:00 PR Newswire
FOOTHILL RANCH, Calif., Sept. 15, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from…